ImmuCell outlines ~$4.5M liquids expansion, targeting more than 3x capacity by end of 2027 (NASDAQ:ICCC)
· seekingalpha.com
ImmuCell (ICCC) Q2 2026 earnings call recap: $7.2M sales, 33.9% gross margin, and $4.5M expansion to triple capacity—read key takeaways now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...